Trials / Completed
CompletedNCT00666185
Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis
A Phase 3, Randomized, Double-Blind, Comparative Trial of Micafungin Versus Fluconazole for the Treatment of Esophageal Candidiasis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 523 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
To determine the efficacy and safety of IV Micafungin versus IV Fluconazole in the treatment of patients with Esophageal Candidiasis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Micafungin | IV |
| DRUG | Fluconazole | IV |
Timeline
- Start date
- 2003-08-01
- Primary completion
- 2004-02-01
- Completion
- 2004-02-01
- First posted
- 2008-04-24
- Last updated
- 2014-09-18
Locations
37 sites across 3 countries: Brazil, Peru, South Africa
Source: ClinicalTrials.gov record NCT00666185. Inclusion in this directory is not an endorsement.